Medidata, a Dassault Systèmes brand and a leader in clinical trial solutions for the life sciences industry, has introduced Medidata Patient Payments, a new solution designed to simplify the process of providing stipends and reimbursements to patients involved in clinical research. This innovative solution automates the payment process, addressing the long-standing challenge of compensating participants for their time, effort, and study-related expenses, while also tackling concerns about the financial burden associated with clinical trials.
Medidata Patient Payments offers a user-friendly reimbursement experience, allowing patients to quickly submit claims for a range of expenses such as travel, meals, lodging, lost wages, childcare, and mileage. The platform automatically triggers stipends based on study activities, like completing assessments or diaries, providing flexibility and convenience. This integrated system ensures a smooth process, facilitating quick setup and meeting the needs of both patients and study sites.
“Our Patient Payments solution reflects our commitment to enhancing the patient experience,” said Meghan Harrington, Vice President of Clinical Trial Financial Management at Medidata. “Through collaboration with Medidata’s patient and site advisory boards, along with our extensive data ecosystem, we are uniquely positioned to modernize financial management for patients.”
Built on the trusted Medidata Platform, Patient Payments is easily accessible through myMedidata for patients and iMedidata accounts for sponsors and sites. Unlike standalone solutions, it is part of a fully integrated e-clinical suite, providing seamless integration and actionable insights throughout the entire study lifecycle.
About Medidata
Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 34,000 trials and 10 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across approximately 2,200 customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC.
